Get started
Live feed
SECFilingvia Quantisnow
Protara Therapeutics Inc. logo

TARA: Amendment: SEC Form SCHEDULE 13G/A filed by Protara Therapeutics Inc.

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for TARA

Across the 19 sessions after earlier TARA headlines, the stock closed higher 10 times and lower 9 times, with a median move of 4.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

TARA close-to-close change in the session after earlier headlines
SessionEarlier headlineTARASPY
May 15, 2026Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC-3.8%-1.2%
May 13, 2026Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update+1.0%+0.6%
Apr 28, 2026Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting+1.4%-0.5%
Mar 10, 2026Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update-0.7%-0.2%
Mar 4, 2026Analyst initiated coverage on Protara Therapeutics with a new price target+0.8%+0.7%
Feb 24, 2026TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer-26.4%+0.7%
Quantisnow market dataNASDAQ
Protara Therapeutics Inc. logo
TARA
Protara Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2014
Get push alerts for TARA

Follow TARA and get a push notification the moment its next story breaks.

Full TARA profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TARA (Protara Therapeutics Inc.) and more on Quantisnow.